While most people are familiar with the common relapsing or progressive types of Multiple Sclerosis, there are several rare and atypical variants of the disease. These rare forms often present with much more aggressive symptoms and unique patterns of brain damage. Clinically, they are sometimes referred to as fulminant or malignant variants because they tend to develop very rapidly. Identifying these rare forms early is critical, as they often require more intensive medical interventions than standard Multiple Sclerosis. Because their appearance on imaging can mimic other serious conditions like brain tumours or infections, a careful diagnostic process is essential to ensure the correct treatment pathway is established.
What we will discuss in this article
- Marburg variant (Acute Fulminant MS) and its rapid course
- Balo concentric sclerosis and its unique onion like lesion pattern
- Tumefactive Multiple Sclerosis and its resemblance to brain tumours
- Schilder disease and its impact on children and adolescents
- How rare variants are distinguished from typical MS on an MRI
- Specialized treatment strategies for aggressive demyelination
- Emergency guidance for severe or rapidly worsening symptoms
Marburg variant (Acute Fulminant MS)
The Marburg variant is a rare and severe form of the disease that progresses much faster than typical Multiple Sclerosis.
Unlike standard forms that may take years to cause significant disability, the Marburg variant can lead to severe neurological impairment within weeks or months. It is characterised by large, widespread areas of inflammation in the brain and spinal cord. Because the inflammation is so intense, it often affects vital areas like the brainstem, which controls basic functions like breathing and swallowing. In the clinical setting, this variant often requires aggressive treatment with high dose steroids, plasma exchange, or potent immunosuppressive medications to stabilize the nervous system and prevent life threatening complications.
Balo concentric sclerosis
In this variant, the damage to the myelin occurs in alternating layers of preserved and destroyed tissue, creating a pattern that looks like the rings of an onion or a bullseye. These concentric lesions are typically found in the white matter of the brain. While it was historically considered a very aggressive condition, modern imaging allows for earlier diagnosis and treatment. Interestingly, some cases of Balo concentric sclerosis are now recognised as being self limiting, with many patients achieving significant recovery when treated promptly with intensive anti-inflammatory therapies.
Tumefactive Multiple Sclerosis
Tumefactive Multiple Sclerosis is a rare variant where the demyelinating lesions are large enough to be mistaken for a brain tumour.
The word tumefactive means tumour-like. These lesions are typically larger than two centimetres and may cause a mass effect, where the lesion physically pushes on the surrounding brain tissue, leading to swelling. Symptoms often include severe headaches, confusion, seizures, or paralysis on one side of the body. Because they look so much like tumours on a standard scan, a brain biopsy is sometimes required to confirm that the mass is actually an area of demyelination rather than a malignancy. Once diagnosed, these large lesions usually respond well to corticosteroids.
Schilder disease
Schilder disease is a very rare form of demyelination that primarily affects children and young adults.
This condition involves massive, symmetrical areas of myelin loss that cover large portions of both brain hemispheres. Symptoms often begin with personality changes, vision loss, or hearing difficulties, eventually progressing to motor and cognitive challenges. It is clinically distinct because the lesions do not follow the typical small, scattered pattern seen in adult Multiple Sclerosis. While it is a serious condition, early intervention with steroids and immunosuppressants has improved the outlook for many young patients.
Diagnosis and intensive management
Diagnosing these rare forms requires a high degree of clinical suspicion and advanced diagnostic tools.
Neurologists use a combination of high-resolution MRI, lumbar punctures to check for specific immune markers, and sometimes biopsies to reach a conclusion. Because these variants are so aggressive, standard disease-modifying therapies used for relapsing remitting MS are often not enough.
- Acute Management: Very high dose intravenous steroids are the first line of defence.
- Plasma Exchange: This involves filtering the blood to remove the antibodies that are attacking the myelin.
- Intensive Immunosuppression: Medications such as monoclonal antibodies are used to rapidly calm the immune system.
Emergency guidance
Rare forms of the disease can cause rapid neurological decline that requires immediate hospital-based care.
Seek immediate medical help if you experience a sudden change in consciousness, a seizure, severe and worsening weakness, or a total loss of vision, as these may indicate an acute, aggressive demyelinating event.
Seek urgent medical advice if you notice:
- A sudden, severe headache that is different from any previous experience
- Rapidly spreading paralysis that involves the muscles used for breathing
- A sudden and total loss of bladder or bowel control
- Signs of severe brain swelling, such as persistent vomiting and extreme drowsiness
- New or worsening cognitive changes that prevent safe daily functioning
To summarise
While most Multiple Sclerosis follows a predictable pattern, rare variants like Marburg, Balo, and Tumefactive MS present unique challenges due to their aggressive nature and atypical imaging. These forms require a specialised diagnostic approach to distinguish them from tumours or infections. Although they are more severe than typical MS, modern clinical strategies involving early, intensive immunosuppression have significantly improved the prognosis for many patients. Understanding these rare variants ensures that even the most aggressive forms of the disease can be managed with the speed and precision needed to protect brain health.
Can a rare form of MS turn into the regular type?
Yes. For example, many people who experience a Tumefactive MS episode eventually go on to follow a more standard Relapsing Remitting MS course.
Is a brain biopsy always necessary for Tumefactive MS?
Not always. With high-resolution MRI and clinical follow-up, many neurologists can confirm the diagnosis without a biopsy, especially if the lesions shrink after steroid treatment.
Are the causes of these rare forms different?
The exact cause is unknown, but they are believed to be part of the same autoimmune spectrum as typical MS, representing a more extreme immune response.
Is Balo concentric sclerosis hereditary?
No, there is no evidence that these rare variants are directly inherited, although general genetic predispositions for autoimmune conditions may play a role.
Why is Balo concentric sclerosis called an onion skin lesion?
The name comes from the alternating rings of damaged and healthy myelin seen on MRI and pathology, which looks remarkably like the layers of an onion.
Do standard MS drugs work for the Marburg variant?
Because Marburg is so aggressive, clinicians often start with much stronger treatments than standard MS drugs, though high efficacy therapies may be used later for long-term control.
Is Schilder disease the same as Adrenoleukodystrophy?
No. Schilder disease is an inflammatory autoimmune condition, while Adrenoleukodystrophy is a genetic metabolic disorder. They can look similar on a scan, which is why genetic testing is often part of the diagnostic process.
Authority Snapshot
This article was reviewed by Dr. Stefan Petrov, a UK trained physician with an MBBS and postgraduate certifications in BLS and ACLS. Dr. Petrov has extensive experience in general medicine, surgery, and emergency care, having worked in both hospital wards and intensive care units. He is committed to medical education and providing detailed, evidence based information to help patients understand complex and rare neurological conditions.
